Imunon, Inc. Operating Lease, Liability, Current
Imunon, Inc. (IMNN) had Operating Lease, Liability, Current of $431.78 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-11
- 2026-06-30: Operating Lease, Liability, Current $431.78K.
- 2026-03-31: Operating Lease, Liability, Current $418.90K.
- 2025-12-31: Operating Lease, Liability, Current $406.35K.
- 2025-09-30: Operating Lease, Liability, Current $394.13K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $431.78K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $418.90K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $406.35K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $394.13K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $382.22K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $394.88K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $452.36K 10-K · filed 2026-03-31 |
| 2024-09-30 | $508.45K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $516.22K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $500.63K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $485.42K 10-K · filed 2025-02-27 |
| 2023-09-30 | $470.61K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $278.41K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $349.60K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $230.75K 10-K · filed 2024-03-28 |
| 2022-09-30 | $373.52K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $459.54K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $516.54K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $548.87K 10-K · filed 2023-03-30 |
| 2021-09-30 | $534.26K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $458.17K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $445.56K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $433.41K 10-K · filed 2022-03-31 |
| 2020-09-30 | $421.56K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $410.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $398.73K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $387.73K 10-K · filed 2021-03-19 |
| 2019-09-30 | $377.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $366.54K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $344.72K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |